Dr. Lauren A. Lukas, MD

Dr. Lukas practices at USC Norris Cancer Hospital in Los Angeles, California.

Dr. Lukas' NPI, 1114150562, was assigned on September 2, 2009. Dr. Lukas graduated from University of Toronto Faculty of Medicine in 2004. Dr. Lukas' California license number on file is A109093.

Dr. Lukas' primary practice is USC Norris Cancer Hospital, at 1441 Eastlake Ave, Los Angeles, CA.

Dr. Lukas' primary practice is USC Norris Cancer Hospital in Los Angeles, California. Dr. Lukas is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Lukas to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lukas practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Lukas' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lukas is board certified in radiation oncology by the American Board of Radiology. Dr. Lukas has a license on file in California.

Dmand AI lists bladder cancer radiation, bone cancer radiation, breast cancer radiation, lung cancer radiation, lymphoma radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Lukas treats.

CMS data shows 2,179 Medicare services from Dr. Lukas across 18 procedure codes in 2024, for 243 Medicare patients. Medicare paid $183,972 for them.

CMS counts 243 Medicare patients who saw Dr. Lukas in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have cancer, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lukas' median patient age at 71, with 25% women.

In 2024, Dr. Lukas wrote 158 Medicare Part D claims for 51 patients. 92% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $627 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Lukas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lukas as offering telehealth.

CMS Open Payments shows 45 general payments to Dr. Lukas from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $457.

Dr. Lukas graduated from University of Toronto Faculty of Medicine in 2004.

Dr. Lukas is in network with 7 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.